Neuropsychopharmacology Reviews | Published:

What has sex got to do with it? The role of hormones in the transgender brain

Neuropsychopharmacologyvolume 44pages2237 (2019) | Download Citation

Abstract

Sex differences and hormonal effects in presumed cisgender individuals have been well-studied and support the concept of a mosaic of both male and female “characteristics” in any given brain. Gonadal steroid increases and fluctuations during peri-puberty and across the reproductive lifespan influence the brain structure and function programmed by testosterone and estradiol exposures in utero. While it is becoming increasingly common for transgender and gender non-binary individuals to block their transition to puberty and/or use gender-affirming hormone therapy (GAHT) to obtain their desired gender phenotype, little is known about the impact of these manipulations on brain structure and function. Using sex differences and the effects of reproductive hormones in cisgender individuals as the backdrop, we summarize here the existing nascent neuroimaging and behavioral literature focusing on potential brain and cognitive differences in transgender individuals at baseline and after GAHT. Research in this area has the potential to inform our understanding of the developmental origins of gender identity and sex difference in response to gonadal steroid manipulations, but care is needed in our research questions and methods to not further stigmatize sex and gender minorities.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Human Rights Campaign. (n.d.). Glossary of terms. http://www.hrc.org/resources/glossary-of-terms. Accessed 16 June 2017.

  2. 2.

    Bale TL, Epperson CN. Sex as a biological variable: who, what, when, why, and how. Neuropsychopharmacology. 2017;42(2):386–96.

  3. 3.

    Bale TL, Epperson CN. Sex differences and stress across the lifespan. Nat Neurosci. 2015;18(10):1413–20.

  4. 4.

    Mueller SC, De Cuypere G, T’Sjoen G. Transgender research in the 21st century: a selective critical review from a neurocognitive perspective. Am J Psychiatry. 2017;174(12):1155–62.

  5. 5.

    Flores AR, Herman JL, Gates GJ, Brown TN. How many adults identify as transgender in the United States? The Williams Institute. 2016.

  6. 6.

    Hansbury G. The middle men: an introduction to the transmasculine identities. Stud Gend Sex. 2005;6(3):241–64.

  7. 7.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Arlington, VA: American Psychiatric Publishing; 1980.

  8. 8.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Arlington, VA: American Psychiatric Publishing; 1994.

  9. 9.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.

  10. 10.

    Glicksman E. Transgender today. Monit Psychol. 2013;44(4):36.

  11. 11.

    Colizzi M, Costa R, Todarello O. Transsexual patients’ psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study. Psychoneuroendocrinology. 2014;39:65–73.

  12. 12.

    Heylens G, Elaut E, Kreukels BP, Paap MC, Cerwenka S, Richter-Appelt H, et al. Psychiatric characteristics in transsexual individuals: multicentre study in four European countries. Br J Psychiatry. 2014;204(2):151–6.

  13. 13.

    Manieri C, Castellano E, Crespi C, Di Bisceglie C, Dell’Aquila C, Gualerzi A, Molo M. Medical treatment of subjects with gender identity disorder: the experience in an Italian public health center. Int J Transgenderism. 2014;15(2):53–65.

  14. 14.

    Sisk CL, Foster DL. The neural basis of puberty and adolescence. Nat Neurosci. 2004;7:1040–7.

  15. 15.

    Arnold AP, Breedlove SM. Organizational and activational effects of sex steroids on brain and behavior: a reanalysis. Horm Behav. 1985;19(4):469–98.

  16. 16.

    Shanmugan S, Epperson CN. Estrogen and the prefrontal cortex: towards a new understanding of estrogen’s effects on executive functions in the menopause transition. Hum Brain Mapp. 2014;35(3):847–65.

  17. 17.

    Shanmugan S, Loughead J, Cao W, Sammel MD, Satterthwaite TD, Ruparel K, et al. Impact of tryptophan depletion on executive system function during menopause is moderated by childhood adversity. Neuropsychopharmacology. 2017a;42(12):2398.

  18. 18.

    Epperson CN, Shanmugan S, Kim DR, Mathews S, Czarkowski KA, Bradley J, et al. New onset executive function difficulties at menopause: a possible role for lisdexamfetamine. Psychopharmacol (Berl). 2015;232(16):3091–3100.

  19. 19.

    Seidman SN. Testosterone deficiency and mood in aging men: pathogenic and therapeutic interactions. World J Biol Psychiatry. 2003;4(1):14–20.

  20. 20.

    McIntyre RS, Mancini D, Eisfeld BS, Soczynska JK, Grupp L, Konarski JZ, Kennedy SH. Calculated bioavailable testosterone levels and depression in middle-aged men. Psychoneuroendocrinology. 2006;31(9):1029–35.

  21. 21.

    McCarthy MM, Arnold AP, Ball GF, Blaustein JD, De Vries GJ. Sex differences in the brain: the not so inconvenient truth. J Neurosci. 2012;32(7):2241–7.

  22. 22.

    Bakker J, Baum MJ. Role for estradiol in female-typical brain and behavioral sexual differentiation. Front Neuroendocrinol. 2008;29(1):1–16.

  23. 23.

    Joel D, Berman Z, Tavor I, Wexler N, Gaber O, Stein Y, et al. Sex beyond the genitalia: the human brain mosaic. Proc Natl Acad Sci. 2015;112(50):15468–73.

  24. 24.

    Bao AM, Swaab DF. Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders. Front Neuroendocrinol. 2011;32(2):214–26.

  25. 25.

    Van Goozen SH, Slabbekoorn D, Gooren LJ, Sanders G, Cohen-Kettenis PT. Organizing and activating effects of sex hormones in homosexual transsexuals. Behav Neurosci. 2002;116(6):982.

  26. 26.

    Gómez-Gil E, Esteva I, Almaraz MC, Pasaro E, Segovia S, Guillamon A. Familiality of gender identity disorder in non-twin siblings. Arch Sex Behav. 2010;39(2):546–52.

  27. 27.

    Satterthwaite TD, Vandekar S, Wolf DH, Ruparel K, Roalf DR, Jackson C, et al. Sex differences in the effect of puberty on hippocampal morphology. J Am Acad Child Adolesc Psychiatry. 2014a;53(3):341–50.

  28. 28.

    Yakovlev PA, Lecours IR. The myelogenetic cycles of regional maturation of the brain. In: Minkowski A, (Ed.). Regional development of the brain in early life. Oxford: Blackwell; 1967. p. 3–70.

  29. 29.

    Huttenlocher PR. Synaptic density in human frontal cortex – developmental changes and effects of aging. Brain Res. 1979;163:195–205.

  30. 30.

    Huttenlocher PR, De Courten C, Garey LJ, Van Der Loos H. Synaptic development in human cerebral cortex. Int J Neurol. 1983;16–17:144–54.

  31. 31.

    Satterthwaite TD, Wolf DH, Roalf DR, Ruparel K, Erus G, Vandekar S, et al. Linked sex differences in cognition and functional connectivity in youth. Cereb Cortex. 2014;25(9):2383–94.

  32. 32.

    Satterthwaite TD, Baker JT. How can studies of resting-state functional connectivity help us understand psychosis as a disorder of brain development? Curr Opin Neurobiol. 2015;30:85–91.

  33. 33.

    Shanmugan S, Satterthwaite TD. Neural markers of the development of executive function: relevance for education. Curr Opin Behav Sci. 2016;10:7–13.

  34. 34.

    Gennatas ED, Avants BB, Wolf DH, Satterthwaite TD, Ruparel K, Ciric R, et al. Age-related effects and sex differences in gray matter density, volume, mass, and cortical thickness from childhood to young adulthood. J Neurosci. 2017;37(20):5065–73.

  35. 35.

    Giedd JN, Vaituzis AC, Hamburger SD, et al. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18 years. J Comp Neurol. 1996;366:223–30.

  36. 36.

    Giedd JN, Castellanos FX, Rajapakse JC, Vaituzis AC, Rapoport JL. Sexual dimorphism of the developing human brain. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:1185–201.

  37. 37.

    Rubia K, Russell T, Overmeyer S, Brammer MJ, Bullmore ET, Sharma T, et al. Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage. 2001;13(2):250–61.

  38. 38.

    Sowell ER, Thompson PM, Tessner KD, Toga AW. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: inverse relationships during postadolescent brain maturation. J Neurosci. 2001;21(22):8819–29.

  39. 39.

    Allen JS, Damasio H, Grabowski TJ. Normal neuroanatomical variation in the human brain: an MRI‐volumetric study. Am J Phys Anthropol. 2002;118(4):341–58.

  40. 40.

    Lüders E, Steinmetz H, Jäncke L. Brain size and grey matter volume in the healthy human brain. Neuroreport. 2002;13(17):2371–4.

  41. 41.

    Ruigrok AN, Salimi-Khorshidi G, Lai MC, Baron-Cohen S, Lombardo MV, Tait RJ, Suckling J. A meta-analysis of sex differences in human brain structure. Neurosci Biobehav Rev. 2014;39:34–50.

  42. 42.

    Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007;62(8):847–55.

  43. 43.

    Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol. 2003;463(1):199–216.

  44. 44.

    Zhou JN, Hofman MA, Gooren LJ, Swaab DF. A sex difference in the human brain and its relation to transsexuality. Nature. 1995;378(6552):68.

  45. 45.

    Kruijver FP, Zhou JN, Pool CW, Hofman MA, Gooren LJ, Swaab DF. Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab. 2000;85(5):2034–41.

  46. 46.

    Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J. 1996;10(5):615–24.

  47. 47.

    Scheinost D, Finn ES, Tokoglu F, Shen X, Papademetris X, Hampson M, Constable RT. Sex differences in normal age trajectories of functional brain networks. Hum Brain Mapp. 2015;36(4):1524–35.

  48. 48.

    Wu K, Taki Y, Sato K, Hashizume H, Sassa Y, Takeuchi H, et al. Topological organization of functional brain networks in healthy children: differences in relation to age, sex, and intelligence. PLOS ONE. 2013;8(2):e55347.

  49. 49.

    Zuo XN, Kelly C, Di Martino A, Mennes M, Margulies DS, Bangaru S, et al. Growing together and growing apart: regional and sex differences in the lifespan developmental trajectories of functional homotopy. J Neurosci. 2010;30(45):15034–43.

  50. 50.

    Casanova R, Whitlow CT, Wagner B, Espeland MA, Maldjian JA. Combining graph and machine learning methods to analyze differences in functional connectivity across sex. Open Neuroimag J. 2012;6:1.

  51. 51.

    Hjelmervik H, Hausmann M, Osnes B, Westerhausen R, Specht K. Resting states are resting traits – an FMRI study of sex differences and menstrual cycle effects in resting state cognitive control networks. PLOS ONE. 2014;9(7):e103492.

  52. 52.

    Miller DI, Halpern DF. The new science of cognitive sex differences. Trends Cogn Sci. 2014;18(1):37–45.

  53. 53.

    Gouchie C, Kimura D. The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology. 1991;16(4):323–34.

  54. 54.

    Kimura D. Sex, sexual orientation and sex hormones influence human cognitive function. Curr Opin Neurobiol. 1996;6(2):259–63.

  55. 55.

    McGlone J. Sex differences in human brain asymmetry: a critical survey. Behav Brain Sci. 1980;3(02):215–27.

  56. 56.

    Mitchell ES, Woods NF. Cognitive symptoms during the menopausal transition and early postmenopause. Climacteric. 2011;14:252–61.

  57. 57.

    Epperson CN, Sammel MD, Freeman EW. Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endocrinol Metab. 2013;98(9):3829–38.

  58. 58.

    Freeman EW, Sammel MD, Boorman DW, Zhang R. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry. 2014;71(1):36-43.

  59. 59.

    Shanmugan S, Loughead J, Nanga RPR, Elliott M, Hariharan H, Appleby D, et al. Lisdexamfetamine effects on executive activation and neurochemistry in menopausal women with executive function difficulties. Neuropsychopharmacology. 2017b;42(2):437.

  60. 60.

    Shanmugan S, Satterthwaite TD, Sammel MD, Cao W, Ruparel K, Gur RC, et al. Impact of early life adversity and tryptophan depletion on functional connectivity in menopausal women: a double-blind, placebo-controlled crossover study. Psychoneuroendocrinology. 2017c;84:197–205.

  61. 61.

    Epperson CN, Amin Z, Ruparel K, Gur R, Loughead J. Interactive effects of estrogen and serotonin on brain activation during working memory and affective processing in menopausal women. Psychoneuroendocrinology. 2012;37(3):372–82.

  62. 62.

    Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63(4):385–90.

  63. 63.

    Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas. 2010;65(2):161–6.

  64. 64.

    Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med. 2004;66(3):356–62.

  65. 65.

    Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Curr Psychiatry Rep. 2017;19(11):83.

  66. 66.

    Goetsch AL, Kimelman D, Woodruff TK . Polycystic Ovary Syndrome. In: Goetsch AL (Ed.) Fertility Preservation and Restoration for Patients with Complex Medical Conditions. Cham: Springer; 2017. p. 231–48.

  67. 67.

    Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8(1):41.

  68. 68.

    Ehrmann DA. Polycystic ovary syndrome. New Engl J Med. 2005;352(12):1223–36.

  69. 69.

    Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update. 2005;11(4):357–74.

  70. 70.

    Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril. 2010;93(7):2421–3.

  71. 71.

    Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv. 2006;61(11):723–32.

  72. 72.

    Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007;87(6):1369–76.

  73. 73.

    Dokras A, Stener-Victorin E, Yildiz BO, Li R, Ottey S, Shah D, Epperson N, Teede H. Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018;109(5):888–99.

  74. 74.

    Rassi A, Veras AB, dos Reis M, Pastore DL, Bruno LM, Bruno RV, de Ávila MA, Nardi AE. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Comprehensive psychiatry. 2010;51(6):599-602.

  75. 75.

    Haring R, Völzke H, Steveling A, Krebs A, Felix SB, Schöfl C, et al. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20–79. Eur Heart J. 2010;31(12):1494–501.

  76. 76.

    Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra A, Perelman MA, et al. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care. 2011;34(7):1669–75.

  77. 77.

    Hyde Z, Flicker L, Almeida OP, Hankey GJ, McCaul KA, Chubb SP, Yeap BB. Low free testosterone predicts frailty in older men: the health in men study. J Clin Endocrinol Metab. 2010;95(7):3165–72.

  78. 78.

    Joshi D, Van Schoor NM, De Ronde W, Schaap LA, Comijs HC, Beekman AT, Lips P. Low free testosterone levels are associated with prevalence and incidence of depressive symptoms in older men. Clin Endocrinol (Oxf). 2010;72(2):232–40.

  79. 79.

    Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab. 2012;97(6):2050–8.

  80. 80.

    Zubiaurre-Elorza L, Junque C, Gómez-Gil E, Segovia S, Carrillo B, Rametti G, Guillamon A. Cortical thickness in untreated transsexuals. Cereb Cortex. 2013;23(12):2855–62.

  81. 81.

    Luders E, Sanchez FJ, Tosun D, Shattuck DW, Gaser C, Vilain E, Toga AW. Increased cortical thickness in male- to-female transsexualism. J Behav Brain Sci. 2012;2:357–62.

  82. 82.

    Simon L, Koza ́k LR, Simon V, Czobor P, Unoka Z, et al. Regional grey matter structure differences between transsexuals and healthy controls – a Voxel Based Morphometry Study. PLOS ONE. 2013;8(12):e83947.

  83. 83.

    Rametti G, Carrillo B, Gómez-Gil E, Junque C, Segovia S, Gomez A, et al. White matter microstructure in female to male transsexuals before cross-sex hormonal treatment. A diffusion tensor imaging study. J Psychiatr Res. 2011;8:1–6.

  84. 84.

    Kranz GS, Hahn A, Kaufmann U, Küblböck M, Hummer A, Ganger S, Lanzenberger R. White matter microstructure in transsexuals and controls investigated by diffusion tensor imaging. J Neurosci. 2014;34(46):15466–75.

  85. 85.

    Hahn A, Kranz GS, Kublbock M, Kaufmann U, Ganger S, Hummer A, Seiger R, Spies M, Winkler D, Kasper S, Windischberger C, Swaab DF, Lanzenberger R. Structural connectivity networks of transgender people. Cereb Cortex. 2015;25:3527–34.

  86. 86.

    Yokota Y, Kawamura Y, Kameya Y. Callosal shapes at the midsagittal plane: MRI differences of normal males, normal females, and GID. In: Proceedings of the 2005 IEEE engineering in medicine and biology 27th annual conference, Shangai, China; 2005. p. 3055–8.

  87. 87.

    Lin CS, Ku HL, Chao HT, Tu PC, Li CT, Cheng CM, et al. Neural network of body representation differs between transsexuals and cissexuals. PLOS ONE. 2014;9(1):e85914.

  88. 88.

    Soleman RS, Schagen SE, Veltman DJ, Kreukels BP, Cohen‐Kettenis PT, Lambalk CB, et al. Sex differences in verbal fluency during adolescence: a functional magnetic resonance imaging study in gender dysphoric and control boys and girls. J Sex Med. 2013;10(8):1969–77.

  89. 89.

    Zucker KJ, Bradley SJ. Gender identity disorder and psychosexual problems in children and adolescents. New York, NY: Guilford Press; 1995.

  90. 90.

    Cohen-Kettenis PT, van Goozen SH, Doorn CD, Gooren LJ. Cognitive ability and cerebral lateralisation in transsexuals. Psychoneuroendocrinology. 1998;23:631–41.

  91. 91.

    Hunt DD, Carr JE, Hampson JL. Cognitive correlates of biologic sex and gender identity in transsexualism. Arch Sex Behav. 1981;10:65–77. 445

  92. 92.

    Berglund H, Lindström P, Dhejne-Helmy C, Savic I. Male-to-female transsexuals show sex-atypical hypothalamus activation when smelling odorous steroids. Cereb Cortex. 2008;18(8):1900–8.

  93. 93.

    Gizewski ER, Krause E, Schlamann M, Happich F, Ladd ME, Forsting M, Senf W. Specific cerebral activation due to visual erotic stimuli in male-to-female transsexuals compared with male and female controls: an fMRI study. J Sex Med. 2009;6:440–8.

  94. 94.

    Junger J, Habel U, Bröhr S, Neulen J, Neuschaefer-Rube C, Birkholz P, et al. More than just two sexes: the neural correlates of voice gender perception in gender dysphoria. PLOS ONE. 2014;9(11):e111672.

  95. 95.

    Hoekzema E, Schagen SE, Kreukels BP, Veltman DJ, Cohen-Kettenis PT, Delemarre-van de Waal H, Bakker J. Regional volumes and spatial volumetric distribution of gray matter in the gender dysphoric brain. Psychoneuroendocrinology. 2015;55:59–71.

  96. 96.

    Luders E, Sánchez FJ, Gaser C, Toga AW, Narr KL, Hamilton LS, Vilain E. Regional gray matter variation in male-to-female transsexualism. Neuroimage. 2009;46(4):904–7.

  97. 97.

    Manzouri A, Kosidou K, Savic I. Anatomical and functional findings in female-to-male transsexuals: testing a new hypothesis. Cereb Cortex. 2017;27(2):998–1010.

  98. 98.

    Haraldsen IR, Opjordsmoen S, Egeland T, Finset A. Sex-sensitive cognitive performance in untreated patients with early onset gender identity disorder. Psychoneuroendocrinology. 2003;28(7):906–15.

  99. 99.

    Forcier MM, Haddad E. Health care for gender variant or gender non-conforming children. R I Med J. 2013;96:17–21.

  100. 100.

    Radix AE. Medical transition for transgender individuals. In: Eckstrand KL, Ehrenfeld JM, editors. Lesbian, gay, bisexual, and transgender healthcare. Switzerland: Springer International Publishing; 2016. p. 351–61.

  101. 101.

    Grant JM, Mottet LA, Tanis J, Herman JL, Harrison J, Keisling M. National transgender discrimination survey report on health and health care. Washington, DC: National Center for Transgender Equality and the National Gay and Lesbian Task Force; 2010.

  102. 102.

    Olson KR, Durwood L, DeMeules M, McLaughlin KA. Mental health of transgender children who are supported in their identities. Pediatrics. 2016;137:e20153223. peds-2015

  103. 103.

    Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab. 2008;93(1):19–25.

  104. 104.

    Van Caenegem E, Wierckx K, Taes Y, Dedecker D, Van de Peer F, Toye K, et al. Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy. J Clin Endocrinol Metab. 2012;97(7):2503–11.

  105. 105.

    Mueller SC, Landre L, Wierckx K, et al. A structural MRI study in transgender persons on cross-sex hormone therapy. Neuroendocrinology. 2017b;105:123–30.

  106. 106.

    Spizzirri G, Duran FLS, Chaim-Avancini TM, Serpa MH, Cavallet M, Pereira CMA, et al. Grey and white matter volumes either in treatment-naïve or hormone-treated transgender women: a voxel-based morphometry study. Sci Rep. 2018;8(1):736.

  107. 107.

    Rametti G, Carrillo B, Gómez-Gil E, Junque C, Zubiaurre-Elorza L, Segovia S, et al. Effects of androgenization on the white matter microstructure of female-to-male transsexuals. A diffusion tensor imaging study. Psychoneuroendocrinology. 2012;37(8):1261–9.

  108. 108.

    Seiger R, Hahn A, Hummer A, Kranz GS, Ganger S, Woletz M, et al. Subcortical gray matter changes in transgender subjects after long-term cross-sex hormone administration. Psychoneuroendocrinology. 2016;74:371–9.

  109. 109.

    Zubiaurre-Elorza L, Junque C, Gómez‐Gil E, Guillamon A. Effects of cross‐sex hormone treatment on cortical thickness in transsexual individuals. J Sex Med. 2014;11(5):1248–61.

  110. 110.

    Burke SM,Manzouri AH,Dhejne C,Bergström K,Arver S,Feusner JD,Savic-Berglund I, Testosterone effects on the brain in transgender men. Cerebral Cortex. 2017;28:1582–96.

  111. 111.

    Hulshoff Pol HE, Cohen-Kettenis PT, Van Haren NEM, Peper JS, Brans RGH, Cahn W, Schnack HG, Gooren LJG, Kahn RS. Changing your sex changes your brain: influences of testosterone and estrogen on adult human brain structure. Eur J Endocrinol. 2006;155:s107–s114.

  112. 112.

    Kranz GS, Hahn A, Kaufmann U, Tik M, Ganger S, Seiger R, et al. Effects of testosterone treatment on hypothalamic neuroplasticity in female-to-male transgender individuals. Brain Struct Funct. 2018;223(1):321–8.

  113. 113.

    Mueller SC, Wierckx K, Jackson K, et al. Circulating androgens correlate with resting-state MRI in transgender men. Psychoneuroendocrinology. 2016;73:91–98.

  114. 114.

    Schöning S, Engelien A, Bauer C, Kugel H, Kersting A, Roestel C, et al. Neuroimaging differences in spatial cognition between men and male-to-female transsexuals before and during hormone therapy. J Sex Med. 2010;7(5):1858–67.

  115. 115.

    Carrillo B, Gómez-Gil E, Rametti G, Junque C, Gomez Á, Karadi K, et al. Cortical activation during mental rotation in male-to-female and female-to-male transsexuals under hormonal treatment. Psychoneuroendocrinology. 2010;35(8):1213–22.

  116. 116.

    Roberts JE, Bell MA. Two- and three-dimensional mental rotation tasks lead to different parietal laterality for men and women. Int J Psychophysiol. 2003;50:235–246.

  117. 117.

    Zacks JM. Neuroimaging studies of mental rotation: a meta-analysis and review. J Cogn Neurosci. 2008;20:1–19.

  118. 118.

    Sommer IEC, Cohen-Kettenis PT, van Raalten T, vd Veer AJ, Ramsey LE, Gooren LJG, et al. Effects of cross-sex hormones on cerebral activation during language and mental rotation: an fMRI study in transsexuals. Eur Neuropsychopharmcol. 2008;18:215e21.

  119. 119.

    Nota NM, Burke SM, den Heijer M, Soleman RS, Lambalk CB, Cohen-Kettenis PT, et al. Brain sexual differentiation and effects of cross-sex hormone therapy in transpeople: a resting-state functional magnetic resonance study. Neurophysiol Clin. 2017;47(5-6):361–70.

  120. 120.

    Schulte-Rüther M, Markowitsch HJ, Shah NJ, Fink GR, Piefke M. Gender differences in brain networks supporting empathy. Neuroimage. 2008;42(1):393–403.

  121. 121.

    Hall JA. Gender effects in decoding nonverbal cues. Psychol Bull. 1978;85(4):845.

  122. 122.

    McClure EB, A meta-analytic review of sex differences in facial expression processing and their development in infants, children, and adolescents. Psychol Bull. 2000;126:424–53.

  123. 123.

    Spies M, Hahn A, Kranz GS, Sladky R, Kaufmann U, Hummer A, et al. Gender transition affects neural correlates of empathy: A resting state functional connectivity study with ultra high-field 7T MR imaging. Neuroimage. 2016;138:257–65.

  124. 124.

    Miles C, Green R, Sanders G, Hines M. Estrogen and memory in a transsexual population. Horm Behav. 1998;34(2):199–208.

  125. 125.

    Gómez-Gil E, Trilla A, Salamero M, Godás T, Valdés M. Sociodemographic, clinical, and psychiatric characteristics of transsexuals from Spain. Arch Sex Behav. 2009;38(3):378–92.

  126. 126.

    Wisniewski AB, Prendeville MT, Dobs AS. Handedness, functional cerebral hemispheric lateralization, and cognition in male-to-female transsexuals receiving cross-sex hormone treatment. Arch Sex Behav. 2005;34(2):167–72.

  127. 127.

    Slabbekoorn D, Van Goozen SH, Megens J, Gooren LJ, Cohen-Kettenis PT. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology. 1999;24(4):423–47.

  128. 128.

    Van Goozen SHM, Cohen-Kettenis PT, Gooren LJG, Frijda NH, Van de Poll NE. Activating effects of androgens on cognitive performance: causal evidence in a group of female-to-male transsexuals. Neuropsychologia. 1994;32:1153–7.

  129. 129.

    Van Goozen SHM, Cohen-Kettenis PT, Gooren LJG, Frijda NH, Van de Poll NE. Gender differences in behaviour: activating effects of cross-gender hormones. Psychoneuroendocrinology. 1995;20:343–63.

  130. 130.

    Paap MCS, Haraldsen IR. Sex-based differences in answering strategy and the influence of cross-sex hormones. Psychiatry Res. 2010;175(3):266–70.

  131. 131.

    Haraldsen IR, Egeland T, Haug E, Finset A, Opjorsdsmoen S. Cross-sex hormone treatment does not change sex-sensitive cognitive performance in gender identity disorder patients. Psychiatry Res. 2005;137:161–74.

  132. 132.

    Miles C, Green R, Hines M. Estrogen effects on cognition, memory and mood in male-to-female transsexuals. Horm Behav. 2006;50:707–8.

  133. 133.

    Terada S, Matsumoto Y, Sato T, Okabe N, Kishimoto Y, Uchitomi Y. Suicidal ideation among patients with gender identity disorder. Psychiatry Res. 2011;190(1):159–62.

  134. 134.

    Clements-Nolle K, Marx R, Katz M. Attempted suicide among transgender persons: the influence of gender-based discrimination and victimization. J Homosex. 2006;51(3):53–69.

  135. 135.

    Almeida J, Johnson RM, Corliss HL, Molnar BE, Azrael D. Emotional distress among LGBT youth: the influence of perceived discrimination based on sexual orientation. J Youth Adolesc. 2009;38(7):1001–14.

  136. 136.

    Grant JM, Mottet LA, Tanis J, Harrison J, Herman JL, Keisling M. Injustice at every turn: a report of the national transgender discrimination survey. National Center for Transgender Equality & National Gay and Lesbian Task Force. Critical national survey describing the recent social context and status of transgender individuals in the US; 2011.

  137. 137.

    Haas AP, Eliason M, Mays VM, et al. Suicide and suicide risk in lesbian, gay, bisexual, and transgender populations: review and recommendations. J Homosex. 2011;58(1):10–51.

  138. 138.

    Maguen S, Shipherd JC. Suicide risk among transgender individuals. Psychol Sex. 2010;1(1):34–43.

  139. 139.

    Dhejne C, Lichtenstein P, Boman M, Johansson AL, Långström N, Landén M. Long-term follow-up of transsexual persons undergoing sex reassignment surgery: cohort study in Sweden. PLOS ONE. 2011;6(2):e16885.

  140. 140.

    Claes L, Bouman WP, Witcomb G, Thurston M, Fernandez‐Aranda F, Arcelus J. Non‐suicidal self‐injury in trans people: associations with psychological symptoms, victimization, interpersonal functioning, and perceived social support. J Sex Med. 2015;12(1):168–79.

  141. 141.

    Hoshiai M, Matsumoto Y, Sato T, Ohnishi M, Okabe N, Kishimoto Y, et al. Psychiatric comorbidity among patients with gender identity disorder. Psychiatry Clin Neurosci. 2010;64(5):514–9.

  142. 142.

    Haraldsen IR, Dahl AA. Symptom profiles of gender dysphoric patients of transsexual type compared to patients with personality disorders and healthy adults. Acta Psychiatr Scand. 2000;102(4):276–81.

  143. 143.

    Bockting WO, Miner MH, Swinburne Romaine RE, Hamilton A, Coleman E. Stigma, mental health, and resilience in an online sample of the US transgender population. Am J Public Health. 2013;103(5):943–51.

  144. 144.

    Fisher AD, Castellini G, Ristori J, Casale H, Cassioli E, Sensi C, et al. Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data. J Clin Endocrinol Metab. 2016;101(11):4260–9.

  145. 145.

    Gorin-Lazard A, Baumstarck K, Boyer L, Maquigneau A, Penochet JC, Pringuey D, et al. Hormonal therapy is associated with better self-esteem, mood, and quality of life in transsexuals. J Nerv Ment Dis. 2013;201(11):996–1000.

  146. 146.

    van Kemenade JF, Cohen-Kettenis PT, Cohen L, Gooren LJ. Effects of the pure antiandrogen RU 23.903 (anandron) on sexuality, aggression, and mood in male-to-female transsexuals. Arch Sex Behav. 1989;18(3):217–28.

  147. 147.

    Leavitt F, Berger JC, Hoeppner JA, Northrop G. Presurgical adjustment in male transsexuals with and without hormonal treatment. J Nerv Ment Dis. 1980;168(11):693–7.

  148. 148.

    Schulster M, Bernie AM, Ramasamy R. The role of estradiol in male reproductive function. Asian J Androl. 2016;18(3):435.

  149. 149.

    Epperson CN, Sammel MD, Bale TL, Kim DR, Conlin S, Scalice S, et al. Adverse childhood experiences and risk for first-episode major depression during the menopause transition. J Clin Psychiatry. 2017;78(3):e298–e307.

  150. 150.

    Nave G,Nadler A,Zava D,Camerer C, Single dose testosterone administration impairs cognitive reflection in men. Psychol Sci. 2017;28:1398–407.

  151. 151.

    Santoro N, Epperson CN, Mathews SB. Menopausal symptoms and their management. Endocrinol Metab Clin North Am. 2015;44(3):497–515.

  152. 152.

    Batrinos ML. Testosterone and aggressive behavior in man. Int J Endocrinol Metab. 2012;10(3):563.

  153. 153.

    van Honk J, Schutter DJ, Hermans EJ, Putman P, Tuiten A, Koppeschaar H. Testosterone shifts the balance between sensitivity for punishment and reward in healthy young women. Psychoneuroendocrinology. 2004;29(7):937–43.

  154. 154.

    Bishop KM, Wahlsten D. Sex differences in the human corpus callosum: myth or reality? Neurosci Biobehav Rev. 1997;21(5):581–601.

  155. 155.

    Weissman M, Bland R, Canino C, Faravelli C, Greenwald S, Hwu H, Joyce P, Karam E, Lee C, Lellouch J, Lépine J, Newman S, Rubio-Stipec M, Wells J, Wickramaratne P, Wittchen H, Yeh E. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293–9.

  156. 156.

    Weissman M, Bland R, Canino G, Greenwald S, Hwu H, Lee C, Newman S, Oakley-Browne M, Rubio-Stipec M, Wickramaratne P, et al. The cross national epidemiology of obsessive compulsive disorder: the cross national collaborative group. J Clin Psychiatry. 1994;55(Suppl.):5–10.

  157. 157.

    Blanton RE, Levitt JG, Peterson JR, Fadale D, Sporty ML, Lee M, et al. Gender differences in the left inferior frontal gyrus in normal children. Neuroimage. 2004;22:626–36.

  158. 158.

    DeLacoste-Utamsing C, Holloway RL. Sexual dimorphism in the human corpus callosum. Science. 1982;216(4553):1431–2.

  159. 159.

    Allen LS, Richey MF, Chai YM, Gorski RA. Sex differences in the corpus callosum of the living human being. J Neurosci. 1991;11(4):933–42.

  160. 160.

    Emory LE, Williams DH, Cole CM, Amparo EG, Meyer WJ. Anatomic variation of the corpus callosum in persons with gender dysphoria. Arch Sex Behav. 1991;20(4):409–17.

  161. 161.

    Gater R, Tansella M, Korten A, Tiemans B, Mavreas V, Olatawura M. Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: report from the World Health Organization Collaborative Study on Psychological Problems in General Health Care. Arch Gen Psychiatry. 1998;55:405–13.

  162. 162.

    Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 1999;2:861–3.

  163. 163.

    Gómez-Gil E, Cañizares S, Torres A, de la Torre F, Halperin I, Salamero M. Androgen treatment effects on memory in female-to-male transsexuals. Psychoneuroendocrinology. 2009;34:110e7.

  164. 164.

    Kessler R, McGonagle K, Zhao S, Nelson C, Hughes M, Eshleman S, Wittchen H, Kendler K. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.

  165. 165.

    Kessler R, Sonnega A, Bromet E, Hughes M, Nelson C. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048–60.

Download references

Acknowledgements

The authors wish to recognize the following funding sources related to the writing of this manuscript: National Institute of Mental Health (NIMH) and Office of Research on Women’s Health (ORWH; P50 MH-099910; CNE); Office of Research on Women’s Health (K12 HD085848); NIMH (K23 MH107831, LH), NIMH (K23 MH102360, SK) and the Emily Hartshorne Mudd Research Fellowship (HBN) and the University of Pennsylvania Center for Undergraduate Research (HBN).

Author information

Affiliations

  1. School of Arts and Sciences, Philadelphia, PA, USA

    • Hillary B. Nguyen
    • , Emily Lipner
    •  & C. Neill Epperson
  2. Penn PROMOTES Research on Sex and Gender in Health, University of Pennsylvania, Philadelphia, PA, USA

    • Hillary B. Nguyen
    • , Emily Lipner
    •  & C. Neill Epperson
  3. Department of Psychiatry, Philadelphia, PA, USA

    • Hillary B. Nguyen
    • , James Loughead
    • , Liisa Hantsoo
    • , Sara L. Kornfield
    •  & C. Neill Epperson
  4. Department of Obstetrics and Gynecology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

    • C. Neill Epperson

Authors

  1. Search for Hillary B. Nguyen in:

  2. Search for James Loughead in:

  3. Search for Emily Lipner in:

  4. Search for Liisa Hantsoo in:

  5. Search for Sara L. Kornfield in:

  6. Search for C. Neill Epperson in:

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to C. Neill Epperson.

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/s41386-018-0140-7

Further reading